JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BKCC
5826
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $38.7K | ﹤0.01% |
+10,000
| New | +$36.4K |
2023 Q4
0 quarters
|
|
5827
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$100M
| $38.7K | ﹤0.01% |
954
-336
| -26% | -$12.7K |
2022 Q4
4 quarters
|
|
5828
Nuveen ESG International Developed Markets Equity ETF
NUDM
$726M
| $38.6K | ﹤0.01% |
1,313
-4,823
| -79% | -$134K |
2023 Q1
3 quarters
|
|
5829
Capital Group Global Growth Equity ETF
CGGO
$11.9B
| $38.6K | ﹤0.01% |
+1,497
| New | +$35.9K |
2023 Q4
0 quarters
|
|
|
GORV
5830
DELISTED
Lazydays
GORV
| $38.5K | ﹤0.01% |
182
-92
| -34% | -$19.2K |
2023 Q2
2 quarters
|
|
5831
Purple Innovation
PRPL
$9.29M
| $38.2K | ﹤0.01% |
1,482
| – | – |
2018 Q3
21 quarters
|
|
|
ALUR
5832
DELISTED
Allurion Technologies
ALUR
| $38.1K | ﹤0.01% |
408
+384
| +1,600% | +$39.1K |
2023 Q3
1 quarter
|
|
|
BRACR
5833
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
| $38.1K | ﹤0.01% |
+325,000
| New | +$43.2K |
2023 Q4
0 quarters
|
|
|
AJXA
5834
DELISTED
Great Ajax Corp.7.25% Convertible Senior Notes due 2024
AJXA
| $38.1K | ﹤0.01% |
+1,550
| New | +$37.9K |
2023 Q4
0 quarters
|
|
|
GDO
5835
Western Asset Global Corporate Defined Opportunity Fund
GDO
$72.6M
| $37.9K | ﹤0.01% |
+2,969
| New | +$35.3K |
2023 Q4
0 quarters
|
|
|
IBTF
5836
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
| $37.8K | ﹤0.01% |
+1,624
| New | +$37.5K |
2023 Q4
0 quarters
|
|
5837
First Trust Financials AlphaDEX Fund
FXO
$1.03B
| $37.7K | ﹤0.01% |
870
| – | – |
2022 Q3
5 quarters
|
|
|
AKTS
5838
DELISTED
Akoustis Technologies Inc
AKTS
| $37.6K | ﹤0.01% |
45,078
| – | – |
2019 Q2
18 quarters
|
|
|
HYPD
5839
Hyperion DeFi Inc
HYPD
$58.2M
| $37.5K | ﹤0.01% |
225
| – | – |
2023 Q2
2 quarters
|
|
5840
Adicet Bio
ACET
$62.2M
| $37.5K | ﹤0.01% |
1,239
-510
| -29% | -$11.1K |
2021 Q2
10 quarters
|
|
|
BTAI
5841
DELISTED
BioXcel Therapeutics
BTAI
| $37.5K | ﹤0.01% |
794
-7
| -0.9% | -$389 |
2019 Q2
18 quarters
|
|
5842
FT Vest US Equity Moderate Buffer ETF March
GMAR
$423M
| $37.4K | ﹤0.01% |
1,121
-17,769
| -94% | -$576K |
2023 Q3
1 quarter
|
|
5843
PUT
Live Nation Entertainment
LYV
$38.9B
| $37.4K | ﹤0.01% |
400
| – | – |
2023 Q3
1 quarter
|
|
5844
Envela
ELA
$316M
| $37.2K | ﹤0.01% |
7,656
+2,738
| +56% | +$11.7K |
2023 Q2
2 quarters
|
|
5845
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.08B
| $37K | ﹤0.01% |
1,750
+985
| +129% | +$19.1K |
2022 Q4
4 quarters
|
|
5846
P3 Health Partners
PIII
$24.5M
| $36.9K | ﹤0.01% |
523
+6
| +1% | +$414 |
2022 Q1
7 quarters
|
|
5847
Santander
BSBR
$39.9B
| $36.7K | ﹤0.01% |
5,608
+1,570
| +39% | +$9.25K |
2023 Q1
3 quarters
|
|
|
LOMA
5848
Loma Negra
LOMA
$1.05B
| $36.7K | ﹤0.01% |
5,173
-31,496
| -86% | -$201K |
2020 Q4
12 quarters
|
|
5849
Tortoise North American Pipeline ETF
TPYP
$829M
| $36.7K | ﹤0.01% |
1,413
+482
| +52% | +$12.2K |
2019 Q3
17 quarters
|
|
5850
iShares International Small Cap Equity Factor ETF
ISCF
$658M
| $36.6K | ﹤0.01% |
1,140
+408
| +56% | +$12.2K |
2023 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.